TCHBF
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and microbodies, and software; Tecan Laberwax, an automation solution; Resolvex, a smart sample preparation solution for use in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA solutions. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; Synergence, platform-based automation solution; and Freedom EVO and Fluent instruments. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | -10.15 | $443M | $48M |
| 2025 Q2 | 1.41 | $439M | $55M |
| 2024 Q4 | 3.55 | $467M | $78M |
| 2024 Q2 | 1.75 | $467M | $40M |
| 2023 Q4 | 6.17 | $533M | $64M |
| 2023 Q2 | 4.17 | $541M | $65M |
| 2022 Q4 | 4.36 | $560M | $37M |
| 2022 Q2 | 5.17 | $584M | $54M |